Belite Bio, Inc American Depositary Shares (BLTE) is a publicly traded Healthcare sector company. As of July 15, 2026, BLTE trades at $146.97 with a market cap of $5.89B and a P/E ratio of 0.00. BLTE moved +0.11% today. Year to date, BLTE is -8.30%; over the trailing twelve months it is +130.70%. Its 52-week range spans $49.00 to $200.00. Analyst consensus is strong buy with an average price target of $216.20. Rallies surfaces BLTE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BLTE financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BLTE recently traded at $146.97. Market cap is $5.89B. P/E ratio is 0.00. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $146.97 |
| Market Cap | $5.89B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $200.00 |
| 52-Week Low | $49.00 |
| Volume | 33.32K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover BLTE: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $216.20.